Onbo IV infusion 300mg, manufactured by Eli Lilly Japan, contains mirikizumab (genetical recombination). This monoclonal antibody targets interleukin-23 (IL-23) to treat moderately to severely active ulcerative colitis and Crohn’s disease in adults. It is supplied as 300mg x 15mL x 1 bottle with YJ code 2399407A1021.
Onbo IV infusion 300mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →